Fiche publication
Date publication
juillet 2023
Journal
Clinical and experimental rheumatology
Auteurs
Membres identifiés du Cancéropôle Est :
Pr ROSSIGNOL Patrick
Tous les auteurs :
Brandão M, Fonseca T, Quelhas Costa R, Oliveira JC, Cyrne Carvalho H, Rodrigues P, Zannad F, Rossignol P, Ferreira MB, Ferreira JP
Lien Pubmed
Résumé
Cardiovascular disease worsens the prognosis of rheumatoid arthritis (RA) and vice-versa. Inflammation may be a common pathway for both conditions. It is expected that a longer RA duration leads to a greater inflammatory cumulative exposure burden; however, studies on the association between RA disease duration and outcomes are scarce. Our aim is to compare the characteristics, biomarker expression and outcomes according to the duration of RA.
Référence
Clin Exp Rheumatol. 2023 07 13;:
